- Q1 2024 Jaguar Health Inc Earnings Call TranscriptMay 14, 2024$16.49 (-5.30%)Earnings
- Q4 2023 Jaguar Health Inc Earnings Call TranscriptApr 01, 2024$4.62 (-14.35%)Earnings
- Q3 2023 Jaguar Health Inc Earnings Call TranscriptNov 14, 2023$19.89 (+6.94%)Earnings
- Jaguar Health Inc at Emerging Growth Conference (Virtual) TranscriptNov 01, 2023
- Q2 2023 Jaguar Health Inc Earnings Call TranscriptAug 14, 2023$32.09 (-6.47%)Earnings
- Ladenburg Thalmann to Host Virtual Discussion with Jaguar Health Inc TranscriptJun 22, 2023
- Jaguar Health Inc at Lytham Partners Spring Investor Conference (Virtual) TranscriptMay 18, 2023
- Q1 2023 Jaguar Health Inc Earnings Call TranscriptMay 15, 2023$45.52 (-22.58%)Earnings
- Q4 2022 Jaguar Health Inc Earnings Call TranscriptMar 27, 2023$62.4 (-7.96%)Earnings
- Jaguar Health Inc Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Entheogen Therapeutics Initiative (ETI) - Corporate Call TranscriptJan 12, 2023
- Q3 2022 Jaguar Health Inc Earnings Call TranscriptNov 14, 2022$632.25 (-6.33%)Earnings
- Q2 2022 Jaguar Health Inc Earnings Call TranscriptAug 22, 2022$1078.2 (-10.09%)Earnings
- Q1 2022 Jaguar Health Inc Earnings Call TranscriptMay 10, 2022$1799.55 (-3.29%)Earnings
- Q4 2021 Jaguar Health Inc Earnings Call TranscriptMar 14, 2022$1697.85 (-3.26%)Earnings
- Q3 2021 Jaguar Health Inc Earnings Call TranscriptNov 17, 2021$7290 (-6.90%)Earnings
- Jaguar Health Inc at Ladenburg Thalmann R&D Webinar TranscriptSep 29, 2021
- Jaguar Health Inc Appoints Karen Brunke Corporate Update Call TranscriptSep 20, 2021
- Q2 2021 Jaguar Health Inc Earnings Call TranscriptAug 13, 2021$16740.02 (-6.77%)Earnings
- Jaguar Health Inc Business Update Call TranscriptJul 29, 2021
- Jaguar Health Inc Innovators with Jane King Webcast TranscriptJun 03, 2021
- Q1 2021 Jaguar Health Inc Earnings Presentation TranscriptMay 17, 2021
- Jaguar Health Inc Napo EU Business Overview Corporate Call TranscriptApr 23, 2021
- Jaguar Health, Inc. - Special Call TranscriptJan 27, 2021
- Jaguar Health, Inc. - Special Call TranscriptJan 14, 2021
- Jaguar Health, Inc. - Special Call TranscriptDec 17, 2020
- Q3 2020 Jaguar Health Inc Earnings Call TranscriptNov 16, 2020$2632.5 (-3.47%)Earnings
- Jaguar Health, Inc. - Special Call TranscriptOct 20, 2020
- Q2 2020 Jaguar Health Inc Earnings Call TranscriptAug 13, 2020$7468.21 (-13.47%)Earnings
- Q1 2020 Jaguar Health Inc Earnings Call TranscriptMay 15, 2020$6647.41 (-2.88%)Earnings
- Q4 2019 Jaguar Health Inc Earnings Call TranscriptApr 06, 2020$6482.71 (-4.91%)Earnings
- Jaguar Health Inc to Discuss Interim Analysis of HALT-D Study of Mytesi (Crofelemer) and Business Updates Conference Call TranscriptNov 14, 2019
- Jaguar Health, Inc. - Special Call TranscriptOct 03, 2019
Jaguar Health, Inc. - Special Call Transcript
Good afternoon. My name is Lisa Conte. I am the founder and CEO of Jaguar Health and our wholly owned subsidiary, Napo Pharmaceuticals, a company committed to novel plant-based prescription drug development. I want to begin by thanking all of you for taking part in our very first Diarrhea Dialogues event.
We've designed the educational event with the key goal of raising awareness among the investor community and global business development context regarding the need for supportive care for people related to chronic, lower gastrointestinal tract distress, specifically the debilitating diarrhea that often results from cancer and cancer therapy, also referred to as cancer therapy related diarrhea, or CTD.
Research shows CTD occurs in up to 80% of cancer patients and is far from a trivial problem. The condition not only has an enormous impact on cancer patients comfort and sensitivity, over 50% of the time diarrhea triggers the need for drug holidays, dose reductions or treatment failure during cancer therapy, which
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)